New therapy targets Hippo pathway to fight treatment-resistant acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid leukemia (AML) through activating the Hippo pathway, a…